Communication of the meeting of Transparency Council No. 20/2026 on 11 May 2026 with resolutions

We invite you to read minutes of the meeting of Transparency Council No. 20/2026 on 11 May 2026 during which the following resolutions were adopted:

1. At its meeting on 11 May 2026, the Transparency Council adopted position No. 61/2026 on the evaluation of the drug Wainzua (eplontersen) under the B.170 drug program: “Treatment of adult patients with stage I or II polyneuropathy associated with hereditary transthyretin amyloidosis (ICD-10: E85.1).”
2. At its meeting on 11 May 2026, the Transparency Council adopted opinion No. 79/2026 on the inclusion of the medicinal product Veyvondi (wonikog alfa) in the health policy program “National Program for the Treatment of Patients with Hemophilia and Related Bleeding Disorders for 2024–2028”
3. At its meeting on 11 May 2026, the Transparency Council adopted opinion No. 80/2026 on the inclusion of the medicinal product Veyvondi (wonikog alfa) in the health policy program “National Program for the Treatment of Patients with Hemophilia and Related Bleeding Disorders for 2024–2028.”
4. At its meeting on 11 May 2026, the Transparency Council adopted position No. 62/2026 on the appropriateness of granting reimbursement approval for the drug Kygevvi (doxecitine and doxribtimine) for the indication: thymidine kinase 2 deficiency.
5. At its meeting on 11 May 2026, the Transparency Council adopted opinion No. 81/2026 on the inclusion of drugs containing the active ingredient abemacyclib in the reimbursement program for indications, dosages, or routes of administration that differ from those specified in the Summary of Product Characteristics.
6. At its meeting on 11 May 2026, the Transparency Council adopted opinion No. 82/2026 on the draft program “Health Policy Program of the Mazovia Province for the Prevention of Post-Traumatic Stress Disorder (PTSD)”
7. At its meeting on 11 May 2026, the Transparency Council adopted opinion No. 83/2026 on the draft program “Health Policy Program for the Early Detection of Vision Defects in Children in Łódź: ‘I See Better’”.

Transparency Council meeting protocol >>